OraSure Technologies OSUR Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

AzentaAZTA

——

BioLife SolutionsBLFS

——

Other financials

Income statement

See full

Revenue$27.9M-6.7%

Gross profit$11.8M-4.0%

Operating income-$23.3M-31.1%

Net income-$22.4M-39.5%

EPS (diluted)-$0.32-52.4%

Balance sheet

See full

Cash & equivalents$177.0M-28.5%

Total debt$12.7M-10.9%

Total equity$313.3M-20.9%

Total assets$379.2M-17.1%

Cash flow

See full

Operating cash flow-$13.9M+29.6%

CapEx$913.0K+117%

Free cash flow-$14.8M+26.5%

Valuation

See full

Market cap$303.62M+35.3%

Enterprise value$139.32M-1,654%

P/S2.7×+1.3×

Profitability

See full

Gross margin42.2%+0.4pp

Operating margin-68.6%-149pp

Net margin-66.4%-115pp

FCF margin-42.4%-43.3pp

Returns & leverage

See full

Return on equity-21.2%-50.4pp

Debt / equity0×0.0×

Current ratio5.5×-6.9×

Where this comes from

Reported directly by OraSure Technologies in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: OraSure Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OraSure Technologies's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OraSure Technologies's cash and cash equivalents, end of period?: OraSure Technologies (OSUR) reported cash and cash equivalents, end of period of $176.96M in Q1 2026.